BOSTON SCIENTIFIC CORPORATION Deferred Tax Liabilities, Gross
BOSTON SCIENTIFIC CORPORATION (BSX) had Deferred Tax Liabilities, Gross of $200.00 million as of 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net
us-gaap:DeferredIncomeTaxLiabilities · last filed 2026-02-17
- 2025-12-31: Deferred Tax Liabilities, Gross $200.00M.
- 2024-12-31: Deferred Tax Liabilities, Gross $222.00M.
- 2023-12-31: Deferred Tax Liabilities, Gross $102.00M.
- 2022-12-31: Deferred Tax Liabilities, Gross $151.00M.
| Period end | Deferred Tax Liabilities, Gross |
|---|---|
| 2025-12-31 | $200.00M 10-K · filed 2026-02-17 |
| 2024-12-31 | $222.00M 10-K · filed 2026-02-17 |
| 2023-12-31 | $102.00M 10-K · filed 2025-02-18 |
| 2022-12-31 | $151.00M 10-K · filed 2024-02-20 |
| 2021-12-31 | $79.00M 10-K · filed 2023-02-23 |
| 2020-12-31 | $47.00M 10-K · filed 2022-02-23 |
| 2019-12-31 | $95.00M 10-K · filed 2021-02-23 |
| 2018-12-31 | $1.04B 10-K · filed 2020-02-25 |
| 2017-12-31 | $1.07B 10-K · filed 2019-02-19 |
| 2016-12-31 | $1.76B 10-K · filed 2018-02-20 |
| 2015-12-31 | $1.88B 10-K · filed 2017-02-23 |
| 2014-12-31 | $2.10B 10-K · filed 2016-02-24 |
| 2013-12-31 | $2.20B 10-K · filed 2015-02-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BECTON DICKINSON & CO (BDX) | United States | $48.834B | 43.79 |
| 3M CO (MMM) | United States | $86.404B | 27.87 |
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| WEST PHARMACEUTICAL SERVICES INC (WST) | United States | $26.288B | 43.14 |
| STRYKER CORP (SYK) | United States | $103.511B | 32.39 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |